Massachusetts Hospital Utilizes New Method for Detecting Colorectal Cancer

Quincy (Mass.) Medical Center has been tapped to conduct a new clinical trial that would assess the efficacy of a GI device aimed at detecting more abnormalities during colonoscopy, according to a Boston Globe news report.

Advertisement

The Third Eye device enables GI physicians to view a 360-degree image of patients’ colons, which reduces the risk of missing colorectal polyps. The device, which is FDA approved, is contained within a traditional colonoscopy but allows physicians to view up to 25 percent more colon abnormalities than a routine colonoscopy, according to the news report.

Read the news report about use of the Third Eye device at Quincy Medical Center.

Read other coverage about colonoscopy:

Detection of Premalignant Colon Polyps Stable Throughout Workday Under Certain Conditions

Position Changes During Colonoscope Withdrawal Can Increase Adenoma Detection Rate

Study: Polypectomy Rate Can Be Used as Quality Measure

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Register to Attend Webinar

Unlocking Structural Heart Capacity: How Leading Programs Use EMR and Data to Improve Patient Flow and Throughput

Wednesday, August 19
11:00 AM - 12:00 PM CDT

Presenters: Katie Kennedy, MSN, APRN, NP-C, Community Heart and VascularMisty Theriot, BSN, RN, CPHQ, FACC, Lake Charles Memorial Health SystemKatie Worthington, DNP, RN, Atlantic Health SystemTaryn Shipley, MBA, CSSBB, Lean HealthTech

Advertisement

Next Up in GI & Endoscopy

Advertisement

Comments are closed.